Predictive factors for multidrug-resistant pathogens in hemodialysis patients with pneumonia : a multicenter study

H. Lee (Jeju, Republic of Korea)

Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Session: CAP: severity scores, risk groups and biomarkers
Session type: Thematic Poster
Number: 4102
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Lee (Jeju, Republic of Korea). Predictive factors for multidrug-resistant pathogens in hemodialysis patients with pneumonia : a multicenter study. 4102

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors and outcomes of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa: a clinical case-control study
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017

Clinical outcomes of the patients with multidrug-resistant Acinetobacter baumannii pneumonia in critical care setting: A retrospective cohort study in Taiwan
Source: International Congress 2018 – Preclinical and clinical studies of critical illness
Year: 2018


Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients
Source: Eur Respir J, 52 (2) 1701190; 10.1183/13993003.01190-2017
Year: 2018



Risk factors for community-acquired pneumonia in hospitalized adult patients, a case-control study
Source: Eur Respir J 2006; 28: Suppl. 50, 351s
Year: 2006

Epidemiology and outcomes in hospitalized patients with health-care-associated pneumonia (HCAP) and community-acquired pneummonia (CAP)~ A prospective observational cohort analysis
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Risk factors for infections with potentially resistant pathogens in patients in a pneumological intensive-care-unit
Source: Eur Respir J 2002; 20: Suppl. 38, 476s
Year: 2002

Community-acquired pneumonia in the elderly: Spanish multicentre study
Source: Eur Respir J 2003; 21: 294-302
Year: 2003



The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study.
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018

Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017


Prospective evaluation of clinical and microbiological parameters in patients with community-acquired pneumonia with and without comorbidity
Source: Eur Respir J 2006; 28: Suppl. 50, 530s
Year: 2006

Predictive factors for true bacteremia and clinical utility of blood cultures as a prognostic tool in patients with community-onset pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016

Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study
Source: Eur Respir J, 54 (1) 1900057; 10.1183/13993003.00057-2019
Year: 2019



Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia
Source: Eur Respir J 2016; 48: 797-807
Year: 2016



Thrombocytosis predicts poor outcomes in patients with community-acquired pneumonia: results from the CAPO international cohort study
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008

Frequency of the occurrence of atypical pathogens in hospitalized patients with CAP: a multi-country study
Source: Eur Respir J 2004; 24: Suppl. 48, 242s
Year: 2004

Feasibility study for a randomized controlled trial of pseudomonas aeruginosa eradication treatment in patients with bronchiectasis
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015


Management of community-acquired pneumonia in primary care: an observational study
Source: International Congress 2019 – Treatment of airway diseases in primary care
Year: 2019


Clinical epidemiology of pneumonia in hemodialysis patients
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012


The impact of hyperglycemia on community-acquired pneumonia: A retrospective cohort study
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007